Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,360,342 papers from all fields of science
Search
Sign In
Create Free Account
PET Response Criteria in Solid Tumors
Known as:
PERCIST
From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. (Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Assessment of tumor response to definitive chemoradiotherapy and prognosis prediction in patients with esophageal cancer judged by PET response criteria in solid tumors: multicenter study in Japan
K. Kitajima
,
H. Kaida
,
+5 authors
R. Minamimoto
Nuclear medicine communications
2020
Corpus ID: 213180716
Objectives The aim of the study was to evaluate PET response criteria in solid tumors (PERCIST) to indicate therapeutic response…
Expand
Review
2014
Review
2014
Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
C. Gámez-Cenzano
,
F. Pino-sorroche
PET Clinics
2014
Corpus ID: 19164436
Highly Cited
2013
Highly Cited
2013
Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation…
A. Maffione
,
A. Ferretti
,
+9 authors
D. Rubello
European Journal of Nuclear Medicine and…
2013
Corpus ID: 11355986
PurposeThe aim of this study was to correlate qualitative visual response and various PET quantification factors with the tumour…
Expand
2013
2013
Proposal of a New 18F-FDG PET/CT Predictor of Response in Rectal Cancer Treated by Neoadjuvant Chemoradiation Therapy and Comparison With PERCIST Criteria
A. Maffione
,
A. Ferretti
,
+6 authors
D. Rubello
Clinical Nuclear Medicine
2013
Corpus ID: 25718392
PurposeThe aim of this study was to correlate PERCIST criteria and a new criterion developed in our center that we named PREDIST…
Expand
Review
2013
Review
2013
A radiologist's guide to treatment response criteria in oncologic imaging: functional, molecular, and disease-specific imaging biomarkers.
P. Rezai
,
M. Pisaneschi
,
Chun Feng
,
V. Yaghmai
AJR. American journal of roentgenology
2013
Corpus ID: 5056033
OBJECTIVE This article reviews the functional, molecular, and disease-specific imaging biomarkers of treatment response…
Expand
2013
2013
Tumor assessment criteria in phase I trials: beyond RECIST.
A. Lévy
,
A. Hollebecque
,
+4 authors
C. Massard
Journal of Clinical Oncology
2013
Corpus ID: 207034000
TO THE EDITOR: In a recent issue of Journal of Clinical Oncology, Jain et al examined the change in tumor size according to…
Expand
2012
2012
Multivariate analysis of various factors affecting background liver and mediastinal standardized uptake values
M. Kuruva
,
B. Mittal
,
M. Abrar
,
R. Kashyap
,
A. Bhattacharya
Indian Journal of Nuclear Medicine
2012
Corpus ID: 41587081
Purpose of the Study: Standardized uptake value (SUV) is the most commonly used semi-quantitative PET parameter. Various response…
Expand
2012
2012
Automated and Robust PERCIST-based Thresholding framework for whole body PET-CT studies
Lei Bi
,
Jinman Kim
,
L. Wen
,
D. Feng
Annual International Conference of the IEEE…
2012
Corpus ID: 17592671
Positron emission tomography (PET) is unique for quantitatively assessing treatment response before marked morphological changes…
Expand
Review
2012
Review
2012
A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma.
J. Herman
,
D. Chang
,
+17 authors
A. Koong
2012
Corpus ID: 220745782
4045 Background: Phase I/II studies with single-fraction (25 Gy) stereotactic body radiotherapy (SBRT) for pancreatic ductal…
Expand
Review
2010
Review
2010
Strategies of assessing and quantifying radiation treatment metabolic tumor response using F18 FDG Positron Emission Tomography (PET)
M. Fuss
Acta oncologica
2010
Corpus ID: 18553674
Abstract The use of positron emission tomography (PET) using F18 labeled fluorodeoxyglucose (FDG) for both oncology disease…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE